Study analysis · Medicine · 2020
Your total testosterone might be normal—but your body could still be starving for male hormone.
As men get older, the active part of testosterone drops steadily, but the total amount doesn’t always go down—so doctors might miss low testosterone if they only check the wrong number.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at how hormone levels change as men get older, but it didn't follow the same men over time. It's like taking a photo of a group of people at different ages and saying 'older people have lower energy'—but we don't know if aging caused it, or if other things like diet or exercise made the difference.
What’s the bottom line?
Scientists studied two groups of Chinese men to see how their hormone levels change as they get older.
How strong is this study?
The study measured hormones carefully, but used two different machines in two different years, which is like using two different rulers to measure the same thing—so the numbers might not match up perfectly. That makes it harder to trust the exact numbers, but we can still see the big picture trends.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
44 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=1498)+20.0/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is a cross-sectional study, which measures variables at a single point in time and cannot determine temporal sequence or rule out confounding factors. Therefore, it cannot establish cause-effect relationships.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding sources were disclosed in the study text. No industry ties or funder involvement were identified.
The study describes two cross-sectional surveys conducted in the same region at different times, with detailed methodology and statistical analysis. However, no funding sources, industry affiliations, or conflict of interest disclosures are mentioned in any section of the text, including methods, ethics, or acknowledgments. While this absence does not confirm absence of conflicts, there is no evidence of bias or industry influence based on the provided text.
Key takeaways
- 01
Free testosterone (the active kind) dropped by about 1–3 pmol per year as men aged; total testosterone didn’t drop consistently—it even went up in one group.
- 02
The older the man, the more likely he was to have low free testosterone: from 1.2% in 40–44 year-olds to 61.6% in 65–69 year-olds.
- 03
Yes—this means many older men may have low active testosterone even if their total testosterone looks normal, which could affect energy, muscle, and mood.
Surprising findings
- Total testosterone increased with age in one study cohort.Everyone assumes testosterone declines with age—but here, in one group of Chinese men, it went up. This contradicts decades of Western research and shows measurement methods and lifestyle factors can flip the narrative.
- Androgen deficiency prevalence ranged from 1.2% to 61.6% depending on the diagnostic threshold.The same population, same age groups, but using different metrics (TT vs cFT) led to a 60-fold difference in diagnosis rates—meaning millions could be misdiagnosed globally.
Practical takeaways
If you're over 45 and feeling fatigued, low-motivated, or losing muscle, ask your doctor for a calculated free testosterone (cFT) test—not just total testosterone.
This study was in Chinese men; reference ranges may vary by ethnicity, and cFT is calculated, not directly measured—so lab quality matters.
medium confidenceWhy this study matters
Free Testosterone Drops—Total Doesn’t
In two Chinese studies, calculated free testosterone (cFT)—the active, unbound form—declined by 1.06 to 2.71 pmol/L per year with age. But total testosterone (TT) didn’t decline consistently: it stayed flat in one group and even increased in another.
Most men and doctors assume total testosterone tells the whole story—but this study shows it can be misleading. You could have ‘normal’ TT but dangerously low cFT, leading to fatigue, low muscle mass, or depression without knowing why.
One Test, 45% vs 17% Diagnosis
Using cFT as the diagnostic threshold, androgen deficiency prevalence jumped from 16.5% to 44.7% across the two studies—more than double the rate when using total testosterone alone.
This isn’t just science—it’s life-changing. A man could be told he’s fine based on total testosterone, but actually have low active hormone levels affecting his energy, mood, and sex drive.
The SHBG Secret Weapon
Sex hormone-binding globulin (SHBG)—a protein that traps testosterone—rose steadily with age and strongly correlated with falling cFT. More SHBG = less free testosterone available to your cells.
It’s not just that testosterone drops—it’s that your body starts locking it away. This explains why supplements might not help if SHBG is high.
The 45–49 Age Cliff
cFT didn’t decline slowly—it dropped sharply starting at age 45–49. In one group, AD prevalence jumped from 25.3% to 38.8% in just five years.
This isn’t gradual aging—it’s a hormonal tipping point. Men in their mid-40s might suddenly feel 'off' without knowing why.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists studied two groups of Chinese men to see how their hormone levels change as they get older.
Research results
Free testosterone (the active kind) dropped by about 1–3 pmol per year as men aged; total testosterone didn’t drop consistently—it even went up in one group. The older the man, the more likely he was to have low free testosterone: from 1.2% in 40–44 year-olds to 61.6% in 65–69 year-olds.
What this means - more context
Yes—this means many older men may have low active testosterone even if their total testosterone looks normal, which could affect energy, muscle, and mood.
To investigate age-related changes in reproductive hormones and prevalence of androgen deficiency in Chinese middle-aged and aging men using two cross-sectional studies.
Two cross-sectional studies in Chinese men (S1: 434, S2: 944 aged 40–69) found that serum calculated free testosterone (cFT) declined annually by 1.06–2.71 pmol/L with aging, while total testosterone (TT) showed inconsistent trends (stable in S1, increased in S2). SHBG increased with age and correlated negatively with cFT. Androgen deficiency prevalence ranged from 16.5% to 44.7% depending on whether TT or cFT was used as the diagnostic threshold, with cFT showing a clear age-related increase.
Methods Used
Two cross-sectional studies conducted 5 years apart in the same Chinese population; serum levels of TT, SHBG, LH, cFT, TSI, and FTI measured using immunoassays; cFT calculated via Vermeulen’s equation; statistical analysis used nonparametric tests and Spearman correlations.
Main Finding
Calculated free testosterone (cFT) declined annually by 1.06–2.71 pmol/L with aging in Chinese men aged 40–69, and prevalence of androgen deficiency increased progressively with age (1.2% to 61.6%) only when using cFT thresholds, not TT thresholds.
Confidence Level
Moderate; findings are consistent within each study but limited by differing assay methods, sample sizes, and potential confounders between cohorts.
Study Flags
Red Flags
- •Different hormone measurement methods between the two studies
- •Inconsistent total testosterone trends across cohorts
- •Potential confounding from lifestyle, BMI, and comorbidities not fully controlled
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Total testosterone increased with age in one study cohort.
Everyone assumes testosterone declines with age—but here, in one group of Chinese men, it went up. This contradicts decades of Western research and shows measurement methods and lifestyle factors can flip the narrative.
Practical Takeaways
If you're over 45 and feeling fatigued, low-motivated, or losing muscle, ask your doctor for a calculated free testosterone (cFT) test—not just total testosterone.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at how hormone levels change as men get older, but it didn't follow the same men over time. It's like taking a photo of a group of people at different ages and saying 'older people have lower energy'—but we don't know if aging caused it, or if other things like diet or exercise made the difference.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Large sample size (n=1498) for a cross-sectional study
- Use of standardized hormone assays and validated calculation methods (e.g., cFT)
- Clear statistical analysis with non-parametric tests for skewed data
Weaknesses
- Cross-sectional design prevents determination of causality or directionality
- Different laboratory methods used in S1 and S2 introduce measurement bias
- Inconsistent sample sizes and age distributions between studies
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists studied two groups of Chinese men to see how their hormone levels change as they get older.
Research results
Free testosterone (the active kind) dropped by about 1–3 pmol per year as men aged; total testosterone didn’t drop consistently—it even went up in one group. The older the man, the more likely he was to have low free testosterone: from 1.2% in 40–44 year-olds to 61.6% in 65–69 year-olds.
What this means - more context
Yes—this means many older men may have low active testosterone even if their total testosterone looks normal, which could affect energy, muscle, and mood.
To investigate age-related changes in reproductive hormones and prevalence of androgen deficiency in Chinese middle-aged and aging men using two cross-sectional studies.
Two cross-sectional studies in Chinese men (S1: 434, S2: 944 aged 40–69) found that serum calculated free testosterone (cFT) declined annually by 1.06–2.71 pmol/L with aging, while total testosterone (TT) showed inconsistent trends (stable in S1, increased in S2). SHBG increased with age and correlated negatively with cFT. Androgen deficiency prevalence ranged from 16.5% to 44.7% depending on whether TT or cFT was used as the diagnostic threshold, with cFT showing a clear age-related increase.
Methods Used
Two cross-sectional studies conducted 5 years apart in the same Chinese population; serum levels of TT, SHBG, LH, cFT, TSI, and FTI measured using immunoassays; cFT calculated via Vermeulen’s equation; statistical analysis used nonparametric tests and Spearman correlations.
Main Finding
Calculated free testosterone (cFT) declined annually by 1.06–2.71 pmol/L with aging in Chinese men aged 40–69, and prevalence of androgen deficiency increased progressively with age (1.2% to 61.6%) only when using cFT thresholds, not TT thresholds.
Confidence Level
Moderate; findings are consistent within each study but limited by differing assay methods, sample sizes, and potential confounders between cohorts.
Study Flags
Red Flags
- •Different hormone measurement methods between the two studies
- •Inconsistent total testosterone trends across cohorts
- •Potential confounding from lifestyle, BMI, and comorbidities not fully controlled
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Total testosterone increased with age in one study cohort.
Everyone assumes testosterone declines with age—but here, in one group of Chinese men, it went up. This contradicts decades of Western research and shows measurement methods and lifestyle factors can flip the narrative.
Practical Takeaways
If you're over 45 and feeling fatigued, low-motivated, or losing muscle, ask your doctor for a calculated free testosterone (cFT) test—not just total testosterone.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at how hormone levels change as men get older, but it didn't follow the same men over time. It's like taking a photo of a group of people at different ages and saying 'older people have lower energy'—but we don't know if aging caused it, or if other things like diet or exercise made the difference.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Large sample size (n=1498) for a cross-sectional study
- Use of standardized hormone assays and validated calculation methods (e.g., cFT)
- Clear statistical analysis with non-parametric tests for skewed data
Weaknesses
- Cross-sectional design prevents determination of causality or directionality
- Different laboratory methods used in S1 and S2 introduce measurement bias
- Inconsistent sample sizes and age distributions between studies
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study measured hormones carefully, but used two different machines in two different years, which is like using two different rulers to measure the same thing—so the numbers might not match up perfectly. That makes it harder to trust the exact numbers, but we can still see the big picture trends.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
44 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=1498)+20.0/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is a cross-sectional study, which measures variables at a single point in time and cannot determine temporal sequence or rule out confounding factors. Therefore, it cannot establish cause-effect relationships.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding sources were disclosed in the study text. No industry ties or funder involvement were identified.
The study describes two cross-sectional surveys conducted in the same region at different times, with detailed methodology and statistical analysis. However, no funding sources, industry affiliations, or conflict of interest disclosures are mentioned in any section of the text, including methods, ethics, or acknowledgments. While this absence does not confirm absence of conflicts, there is no evidence of bias or industry influence based on the provided text.